This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/chemspider/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/chebi/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/kegg-compound/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02056/identifier/drugbank/

Statements

Subject Item
n2:DB02056
rdf:type
n3:Drug
n3:description
The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. [PubChem]
n3:group
experimental
owl:sameAs
n14:DB02056 n16:DB02056
dcterms:title
(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid
adms:identifier
n6:46504574 n7:PG2 n8:448457 n9:DB02056 n10:C00696 n11:15555 n12:395250
n3:IUPAC-Name
n4:271B6086-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B608C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B608B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6088-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6089-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B608A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6084-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6082-363D-11E5-9242-09173F13E4C5 n4:271B6085-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6083-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6092-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6093-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B608D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B608E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6090-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B608F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6091-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
41598-07-6
n3:Bioavailability
n4:271B6098-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B609A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B609B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6097-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6096-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6099-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6087-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6094-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6095-363D-11E5-9242-09173F13E4C5